Perpetual Ltd reduced its stake in MakeMyTrip Limited (NASDAQ:MMYT - Free Report) by 54.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,211 shares of the technology company's stock after selling 5,032 shares during the period. Perpetual Ltd's holdings in MakeMyTrip were worth $413,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Steward Partners Investment Advisory LLC boosted its stake in MakeMyTrip by 41.4% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 379 shares of the technology company's stock valued at $43,000 after acquiring an additional 111 shares during the period. Parallel Advisors LLC boosted its stake in MakeMyTrip by 1,014.9% in the first quarter. Parallel Advisors LLC now owns 524 shares of the technology company's stock valued at $51,000 after acquiring an additional 477 shares during the period. Signaturefd LLC acquired a new position in MakeMyTrip in the fourth quarter valued at approximately $74,000. Gen Wealth Partners Inc boosted its stake in MakeMyTrip by 29.5% in the fourth quarter. Gen Wealth Partners Inc now owns 725 shares of the technology company's stock valued at $81,000 after acquiring an additional 165 shares during the period. Finally, E Fund Management Hong Kong Co. Ltd. acquired a new position in MakeMyTrip in the first quarter valued at approximately $107,000. 51.89% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on MMYT shares. Macquarie raised MakeMyTrip from a "neutral" rating to an "outperform" rating and set a $110.00 price target on the stock in a report on Tuesday, June 24th. Citigroup lifted their price target on MakeMyTrip from $120.00 to $125.00 and gave the company a "buy" rating in a report on Thursday, May 15th. Finally, Wall Street Zen raised MakeMyTrip from a "sell" rating to a "hold" rating in a report on Thursday, May 15th.
View Our Latest Stock Analysis on MMYT
MakeMyTrip Stock Performance
MMYT opened at $99.82 on Friday. The business's 50 day moving average is $101.90 and its 200-day moving average is $103.30. The stock has a market cap of $11.11 billion, a PE ratio of 120.27 and a beta of 0.88. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.01. MakeMyTrip Limited has a twelve month low of $76.95 and a twelve month high of $123.00.
MakeMyTrip Company Profile
(
Free Report)
MakeMyTrip Limited, an online travel company, sells travel products and solutions in India, the United States, Singapore, Malaysia, Thailand, the United Arab Emirates, Peru, Colombia, Vietnam, and Indonesia. The company operates through three segments: Air Ticketing, Hotels and Packages, and Bus Ticketing.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MakeMyTrip, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MakeMyTrip wasn't on the list.
While MakeMyTrip currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
